DBT(EPA:ALDBT) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALDBT. ALDBT was compared to 60 industry peers in the Electrical Equipment industry. ALDBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALDBT is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALDBT had negative earnings in the past year.

ALDBT had a negative operating cash flow in the past year.

ALDBT had negative earnings in each of the past 5 years.

ALDBT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of ALDBT (-26.45%) is worse than 83.33% of its industry peers.

With a Return On Equity value of -52.13%, ALDBT is not doing good in the industry: 78.33% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-26.45%
ROE	-52.13%
ROIC	N/A

ROA(3y)-33.36%

ROA(5y)-29.74%

ROE(3y)-63.54%

ROE(5y)-60%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALDBT has a Gross Margin of 30.74%. This is comparable to the rest of the industry: ALDBT outperforms 46.67% of its industry peers.

ALDBT's Gross Margin has declined in the last couple of years.

ALDBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	30.74%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-25.54%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALDBT does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALDBT has more shares outstanding

Compared to 5 years ago, ALDBT has less shares outstanding

The debt/assets ratio for ALDBT is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.04, we must say that ALDBT is in the distress zone and has some risk of bankruptcy.

ALDBT has a worse Altman-Z score (-0.04) than 73.33% of its industry peers.

There is no outstanding debt for ALDBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-0.04

ROIC/WACCN/A

WACC6.77%

2.3 Liquidity

ALDBT has a Current Ratio of 1.02. This is a normal value and indicates that ALDBT is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of ALDBT (1.02) is worse than 76.67% of its industry peers.

A Quick Ratio of 0.66 indicates that ALDBT may have some problems paying its short term obligations.

With a Quick ratio value of 0.66, ALDBT is not doing good in the industry: 76.67% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.02
Quick Ratio	0.66

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALDBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.78%, which is quite impressive.

Looking at the last year, ALDBT shows a decrease in Revenue. The Revenue has decreased by -3.98% in the last year.

ALDBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.99% yearly.

EPS 1Y (TTM)77.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)-3.98%

Revenue growth 3Y39.23%

Revenue growth 5Y2.99%

Sales Q2Q%-3.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

ALDBT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 1293.96% yearly.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year170836%

Revenue Next 2Y4524.17%

Revenue Next 3Y1293.96%

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALDBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year ALDBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALDBT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DBT

EPA:ALDBT (3/7/2025, 7:00:00 PM)

0.527

-0.04 (-6.73%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.23%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap2.65M

Analysts84.44

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.25
P/FCF	N/A
P/OCF	N/A
P/B	0.18
P/tB	0.21
EV/EBITDA	N/A

EPS(TTM)-5.7

EYN/A

EPS(NY)-4.97

Fwd EYN/A

FCF(TTM)-2.37

FCFYN/A

OCF(TTM)-1.02

OCFYN/A

SpS2.08

BVpS2.88

TBVpS2.48

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-26.45%
ROE	-52.13%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	30.74%
FCFM	N/A

ROA(3y)-33.36%

ROA(5y)-29.74%

ROE(3y)-63.54%

ROE(5y)-60%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-25.54%

F-Score3

Asset Turnover0.37

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.02
Quick Ratio	0.66
Altman-Z	-0.04

F-Score3

WACC6.77%

ROIC/WACCN/A

Cap/Depr(3y)331.85%

Cap/Depr(5y)327.48%

Cap/Sales(3y)38.5%

Cap/Sales(5y)30.6%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)77.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-3.98%

Revenue growth 3Y39.23%

Revenue growth 5Y2.99%

Sales Q2Q%-3.85%

Revenue Next Year170836%

Revenue Next 2Y4524.17%

Revenue Next 3Y1293.96%

Revenue Next 5YN/A

EBIT growth 1Y-4.13%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-89198.2%

EBIT Next 3Y-666.44%

EBIT Next 5YN/A

FCF growth 1Y-51.6%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y25.85%

OCF growth 3YN/A

OCF growth 5YN/A

DBT (ALDBT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens